Duggan MA - Search Results

1

Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study.

Köbel M, Kalloger SE, Baker PM, Ewanowich CA, Arseneau J, Zherebitskiy V, Abdulkarim S, Leung S, Duggan MA, Fontaine D, Parker R, Huntsman DG, Gilks CB. Köbel M, et al. Among authors: duggan ma. Am J Surg Pathol. 2010 Jul;34(7):984-93. doi: 10.1097/PAS.0b013e3181e1a3bb. Am J Surg Pathol. 2010. PMID: 20505499

2

The cytokeratin profiles of ovarian common "epithelial" tumors.

Duggan MA, Robertson DI. Duggan MA, et al. Eur J Gynaecol Oncol. 1989;10(2):73-9. Eur J Gynaecol Oncol. 1989. PMID: 2470591

3

The accuracy and interobserver reproducibility of endometrial dating.

Duggan MA, Brashert P, Ostor A, Scurry J, Billson V, Kneafsey P, Difrancesco L. Duggan MA, et al. Pathology. 2001 Aug;33(3):292-7. Pathology. 2001. PMID: 11523927

4

Reproducibility of histological cell type in high-grade endometrial carcinoma.

Han G, Sidhu D, Duggan MA, Arseneau J, Cesari M, Clement PB, Ewanowich CA, Kalloger SE, Köbel M. Han G, et al. Among authors: duggan ma. Mod Pathol. 2013 Dec;26(12):1594-604. doi: 10.1038/modpathol.2013.102. Epub 2013 Jun 28. Mod Pathol. 2013. PMID: 23807777 Free article.

5

Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium.

Köbel M, Kalloger SE, Lee S, Duggan MA, Kelemen LE, Prentice L, Kalli KR, Fridley BL, Visscher DW, Keeney GL, Vierkant RA, Cunningham JM, Chow C, Ness RB, Moysich K, Edwards R, Modugno F, Bunker C, Wozniak EL, Benjamin E, Gayther SA, Gentry-Maharaj A, Menon U, Gilks CB, Huntsman DG, Ramus SJ, Goode EL; Ovarian Tumor Tissue Analysis consortium. Köbel M, et al. Among authors: duggan ma. Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1677-86. doi: 10.1158/1055-9965.EPI-13-0391. Epub 2013 Jul 23. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23880734 Free PMC article.

6

MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome.

Nelson GS, Pink A, Lee S, Han G, Morris D, Ogilvie T, Duggan MA, Köbel M. Nelson GS, et al. Among authors: duggan ma. Gynecol Oncol. 2013 Nov;131(2):309-14. doi: 10.1016/j.ygyno.2013.08.003. Epub 2013 Aug 11. Gynecol Oncol. 2013. PMID: 23938375

7

Primary squamous cell carcinoma of the endometrium: clinicopathologic and molecular characteristics.

Bures N, Nelson G, Duan Q, Magliocco A, Demetrick D, Duggan MA. Bures N, et al. Among authors: duggan ma. Int J Gynecol Pathol. 2013 Nov;32(6):566-75. doi: 10.1097/PGP.0b013e31828cb0be. Int J Gynecol Pathol. 2013. PMID: 24071873

8

PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.

McIntyre JB, Nelson GS, Ghatage P, Morris D, Duggan MA, Lee CH, Doll CM, Köbel M. McIntyre JB, et al. Among authors: duggan ma. Gynecol Oncol. 2014 Jan;132(1):188-93. doi: 10.1016/j.ygyno.2013.11.015. Epub 2013 Nov 19. Gynecol Oncol. 2014. PMID: 24262879

9

POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.

Meng B, Hoang LN, McIntyre JB, Duggan MA, Nelson GS, Lee CH, Köbel M. Meng B, et al. Among authors: duggan ma. Gynecol Oncol. 2014 Jul;134(1):15-9. doi: 10.1016/j.ygyno.2014.05.006. Epub 2014 May 16. Gynecol Oncol. 2014. PMID: 24844595

10

Napsin A: Another milestone in the subclassification of ovarian carcinoma.

Köbel M, Duggan MA. Köbel M, et al. Among authors: duggan ma. Am J Clin Pathol. 2014 Dec;142(6):735-7. doi: 10.1309/AJCPAVGZKA1A1HVC. Am J Clin Pathol. 2014. PMID: 25389324 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page